When should repetitive nerve stimulation (RNS), evoked potentials (visual evoked potentials, somatosensory evoked potentials, brainstem auditory evoked potentials), and sudoscan be ordered, and what is their diagnostic utility for neuromuscular‑junction disorders, demyelinating central nervous system disease, and small‑fiber neuropathy or autonomic dysfunction?

Diagnostic Utility of RNS, Evoked Potentials, and Sudoscan

Order repetitive nerve stimulation (RNS) when you suspect a neuromuscular junction disorder based on fatigable weakness; visual evoked potentials (VEP) when MRI findings are limited or atypical in suspected demyelinating disease; and skin biopsy with intraepidermal nerve fiber density (IENF) rather than sudoscan for small fiber neuropathy diagnosis.

Repetitive Nerve Stimulation (RNS)

When to Order

• Order RNS when clinical presentation suggests neuromuscular junction pathology—specifically fatigable weakness that worsens with repetitive activity 1, 2.
• The test unmasks reduced safety factor at the neuromuscular junction through depletion of acetylcholine stores at the presynaptic terminal 1.

Diagnostic Utility

• Low-frequency RNS (2-5 Hz) demonstrates decremental responses in postsynaptic disorders (myasthenia gravis), while high-frequency stimulation or brief exercise reveals facilitated responses in presynaptic disorders (Lambert-Eaton myasthenic syndrome) by augmenting presynaptic calcium levels 1.
• Activation with isometric exercise increases sensitivity of RNS testing 1.
• Critical caveat: RNS has high sensitivity but limited specificity—technical detail and reproducibility are essential for valid results 1, 2.

Technical Considerations

• Single fiber EMG (SFEMG) assesses jitter (temporal variability in muscle fiber action potentials) and provides higher sensitivity than standard RNS when neuromuscular junction dysfunction is suspected but RNS is negative 1, 2.

Evoked Potentials

Visual Evoked Potentials (VEP)

When to Order

• Order VEP when MRI abnormalities are few (particularly in primary progressive MS with progressive myelopathy) 3.
• Order VEP when MRI abnormalities have lesser specificity—in older individuals with microvascular disease risk factors or when radiological findings don't satisfy MRI specificity criteria for MS diagnosis 3.
• VEP provides additional objective evidence of dissemination in space when clinical presentation alone is insufficient 3.

Diagnostic Utility

• VEP can detect clinically "silent" lesions in demyelinating disease, particularly in the visual pathways 4.
• While MRI is the most sensitive and specific test for MS diagnosis, VEP adds complementary information when imaging is limited or equivocal 3.

Somatosensory Evoked Potentials (SSEP)

When to Order

• Order SSEP to assess functional integrity of sensory pathways when imaging is inconclusive 5, 6.
• Useful for both central and peripheral nervous system disorders affecting the ascending somatosensory pathways 5, 6.

Diagnostic Utility

• SSEPs measure electrical potentials along the entire somatosensory pathway from peripheral nerve to cortex 5, 6.
• They complement clinical examination and peripheral neurophysiological studies, particularly when structural imaging doesn't explain sensory deficits 6.
• Established applications include intraoperative monitoring and intensive care unit recordings 5.

Brainstem Auditory Evoked Potentials (BAEP)

Limited Utility

• Other types of evoked potential analysis (including BAEP) contribute little to MS diagnosis compared to VEP 3.
• Consider only when specific brainstem pathology is suspected and other diagnostic modalities are inconclusive.

Sudoscan vs. Skin Biopsy for Small Fiber Neuropathy

The Superior Choice: Skin Biopsy

When to Order

• Order skin biopsy with IENF density assessment in symptomatic patients with suspected small fiber sensory neuropathy (SFSN) when they present with burning pain, tingling, or numbness but have normal nerve conduction studies 7, 8, 9.
• Particularly valuable when autonomic symptoms (orthostatic dizziness) accompany sensory complaints 8, 9.

Diagnostic Utility

• Skin biopsy with IENF density using PGP 9.5 immunohistochemistry is the gold standard for SFSN diagnosis—it is a validated, reproducible, safe technique that directly measures small fiber loss 7, 8, 9.
• IENF assessment distinguishes polyneuropathy patients (including SFSN) from normal controls with high diagnostic efficiency 7.
• The technique provides objective documentation of unmyelinated C fiber terminals, which are predominantly affected in SFSN 7.

Sudoscan (QSART) Considerations

When to Consider

• Quantitative sudomotor axon reflex testing (QSART/sudoscan) documents sudomotor axon loss and autonomic dysfunction with high sensitivity 7.
• Useful to confirm small fiber polyneuropathy when autonomic features predominate 7.

Limitations

• The evidence base strongly favors skin biopsy over sudoscan—while QSART can document small fiber loss, skin biopsy provides direct histological evidence and is better validated 7.
• Research comparing the two techniques is needed, but skin biopsy remains the established standard 7.

Algorithmic Approach

For Suspected Neuromuscular Junction Disorder:

1. Start with low-frequency RNS (look for >10% decrement)
2. If negative but suspicion remains high, proceed to SFEMG
3. Consider high-frequency RNS or post-exercise facilitation if presynaptic disorder suspected 1, 2

For Suspected Demyelinating CNS Disease:

1. MRI is first-line imaging
2. Add VEP when: MRI shows few lesions, patient has progressive myelopathy, or MRI specificity is reduced (older patients, vascular risk factors)
3. Reserve other evoked potentials (SSEP, BAEP) for specific clinical scenarios where imaging is inconclusive 3, 5, 6

For Suspected Small Fiber Neuropathy:

1. Perform nerve conduction studies to exclude large fiber neuropathy
2. Order skin biopsy with IENF density as the definitive diagnostic test
3. Consider autonomic testing (QSART/sudoscan) as adjunctive when autonomic symptoms are prominent, but not as a replacement for skin biopsy 7, 8, 9